SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response

Between June and November 2020, we assessed plasma antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid protein in 4996 participants (aged 18–82 years, 34.5% men) from the National and Kapodistrian University of Athens. The weighted overall prevalence was 1.6%...

Full description

Bibliographic Details
Main Authors: Ourania E. Tsitsilonis, Dimitrios Paraskevis, Evi Lianidou, Evangelos Terpos, Athanasios Akalestos, Vassilios Pierros, Evangelia Georgia Kostaki, Efstathios Kastritis, Paraskevi Moutsatsou, Marianna Politou, Andreas Scorilas, Thomas Sphicopoulos, Nikolaos Thomaidis, Ioannis P. Trougakos, Athanassios Tsakris, Nikolaos Voulgaris, Christina C. Daskalaki, Zoi Evangelakou, Christina Fouki, Despoina D. Gianniou, Sentiljana Gumeni, Ioannis V. Kostopoulos, Maria S. Manola, Nikolaos Orologas-Stavrou, Chrysanthi Panteli, Eleni-Dimitra Papanagnou, Pantelis Rousakis, Aimilia D. Sklirou, Stavroula Smilkou, Dimitra Stergiopoulou, Sotirios Tsiodras, Meletios-Athanasios Dimopoulos, Petros P. Sfikakis
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/9/3/207